Patient Characteristics
| Mean age (yrs) | 24 (1-56) |
| Sex (male:female) | 20:21 |
| Pretransplant diagnosis | |
| Acute lymphoblastic leukemia | 11 |
| Acute myelogenous leukemia | 9 |
| Chronic myelogenous leukemia | 6 |
| Myelodysplastic syndrome | 7 |
| Other-150 | 8 |
| Allogeneic T-cell–depleted marrow grafts-151 | 18 |
| Unmodified marrow | 16 |
| Unrelated cord blood | 3 |
| Autologous, T-cell–depleted transplant | 1 |
| Autologous peripheral blood | 3 |
| Mean age (yrs) | 24 (1-56) |
| Sex (male:female) | 20:21 |
| Pretransplant diagnosis | |
| Acute lymphoblastic leukemia | 11 |
| Acute myelogenous leukemia | 9 |
| Chronic myelogenous leukemia | 6 |
| Myelodysplastic syndrome | 7 |
| Other-150 | 8 |
| Allogeneic T-cell–depleted marrow grafts-151 | 18 |
| Unmodified marrow | 16 |
| Unrelated cord blood | 3 |
| Autologous, T-cell–depleted transplant | 1 |
| Autologous peripheral blood | 3 |
The clinical characteristics of patients evaluated by semiquantitative EBV PCR are summarized above.
Includes 2 patients with non-Hodgkin's lymphoma, 3 patients with Ewing's sarcoma, 1 patient with neuroblastoma, 1 patient with juvenile myelomonocytic leukemia, and 1 patient with multiple sclerosis.
T-cell depletion by sheep erythrocyte and soybean agglutination (15) or CD34 selection device.3